Federal Circuit Bar Association Annual Bench & Bar Conference
PTAB Practice in the Pharmaceutical Industry
Panelist: Shareholder Erin Dunston
Saturday, June 24, 8:45 AM-10:00 AM
Shareholder Erin Dunston, Sanofi Principal Counsel Brian McCaslin, Mylan Assistant General Counsel Thomas Jenkins, and USPTO Chief Judge David Ruschke will lead the panel, PTAB Practice in the Pharmaceutical Industry.
Inter partes review (“IPR”) has increasingly become a method of choice for challenging life sciences patents, including those related to blockbuster biopharmaceuticals and medical devices. This panel will discuss the various strategic considerations and challenges unique to life sciences IPRs, including when IPRs are used in the context of co-pending district court litigation. The panel will also discuss how strategic approaches may differ depending upon the particular type of biopharmaceutical at issue, including complex biologics and small molecules.